Aflac Incorporated (NYSE:AFL) shares traded -2.24% lower at $64.56 on Wall Street last session.
In accordance with the data, 16 analysts cover Aflac Incorporated (NYSE:AFL). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $80.00 and a low of $57.00, we find $70.00. Given the previous closing price of $66.04, this indicates a potential upside of 6.0 percent. AFL stock price is now -1.58% away from the 50-day moving average and -2.34% away from the 200-day moving average. The market capitalization of the company currently stands at $39.03B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
It has been rated a hold by 12 analysts and a buy by 2. Brokers who have rated the stock have averaged $70.67 as their price target over the next twelve months.
In other news, MOSKOWITZ JOSEPH L, Director sold 13,471 shares of the company’s stock on May 19. The stock was sold for $906,140 at an average price of $67.27. Upon completion of the transaction, the Director now directly owns 27,570 shares in the company, valued at $1.78 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 12, SVP, CFO, Aflac US BEAVER STEVEN KENT sold 13,118 shares of the business’s stock. A total of $870,119 was realized by selling the stock at an average price of $66.33. This leaves the insider owning 20,793 shares of the company worth $1.34 million. Insiders disposed of 585,443 shares of company stock worth roughly $37.8 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in AFL stock. A new stake in Aflac Incorporated shares was purchased by ALYESKA INVESTMENT GROUP, L.P. during the first quarter worth $19,119,000. BROOKFIELD CORP /ON/ invested $11,743,000 in shares of AFL during the first quarter. In the first quarter, VOLORIDGE INVESTMENT MANAGEMENT, LLC acquired a new stake in Aflac Incorporated valued at approximately $11,131,000. MKP CAPITAL MANAGEMENT, L.L.C. acquired a new stake in AFL for approximately $4,477,000. GRAHAM CAPITAL MANAGEMENT, L.P. purchased a new stake in AFL valued at around $4,439,000 in the second quarter. In total, there are 1,638 active investors with 60.60% ownership of the company’s stock.
Aflac Incorporated (NYSE: AFL) opened at $65.50 on Wednesday. During the past 12 months, Aflac Incorporated has had a low of $52.07 and a high of $74.01. According to the stock market information, the enterprise value for the company is $46.23B, which is based on a 9.34 price-to-earnings ratio, a 8.26 price-to-earnings-growth ratio, and a beta of 0.94. The fifty day moving average price for AFL is $65.63 and a two-hundred day moving average price translates $66.13 for the stock.
The latest earnings results from Aflac Incorporated (NYSE: AFL) was released for Mar, 2023. The net profit margin was 22.90% and return on equity was 19.30% for AFL. For the current quarter, analysts expect AFL to generate $4.54B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 06/01/2023. Investors who held shares on 05/17/2023 were paid a $0.42 dividend. On an annualized basis, this represents a $1.68 dividend and a 2.60% percent yield. There was an ex-dividend date of 05/16/2023 for this dividend. In terms of dividend payout ratio, AFL is presently at 23.30%.
Aflac Incorporated(AFL) Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is headquartered in Columbus, Georgia.
Leave a Reply